• C. The target compounds were obtained in high yields and were regioisomerically pure after recrystallization. These new heterocycles may act as potential MAO B inhibitors.
Introduction
Multicomponent reactions (MCRs) are one-pot processes in which three or more reactants come together in a single reaction vessel to form a product containing substantial elements of all the reactants.
1−4 MCRs, leading to interesting heterocyclic scaffolds, are particularly useful for combinatorial chemistry as powerful tools,
5−9
because of their valuable features such as atom economy, environmental friendliness, straightforward reaction design, and the opportunity to construct target compounds by the introduction of several diverse elements in a single chemical operation. 10−14 Therefore, a great deal of current interest is focused on the development of novel MCRs.
15
Substituted pyridazines are valuable therapeutic agents and are the subunits of multiple classes of natural products. 16, 17 The synthesis and utility of many pyridazine derivatives as analgesics, insecticidals, 18 fungicidals, 19 cardiotonics, 20 and bacteriocides 21 have been reported. Moreover, fused pyridazines and their derivatives are known to exhibit pharmacological properties, for example, as anti-inflammatory 22 and antibacterial agents, 23 protein tyrosine phosphatase inhibitors, 24 and anticancer agents. 25 In particular, pyrimido[4, MAO inhibitory activity, and substituents on the diazine nucleus modulate the inhibitory activity.
29
Monoamine oxidase (MAO) is a ubiquitous membrane-bound, flavin-containing enzyme particularly abundant in the liver and brain. 30 In mammals, two distinct isoforms of MAO are present in most tissues, As such, the development of synthetic methodologies that combine high levels of regiocontrol and flexibility continues to be intensively researched within organic chemistry.
Recently, we have been interested in regioselective one-pot synthesis of various heterocyclic compounds.
37−45
Following our previous reports about the synthesis of 3-or 4-aryl substituted pyrimido [4,5-c ] pyridazines, 40, 43, 45 herein we wish to report the synthesis of new substituted pyrimidopyridazines as 3-aryl-6-methylpyrimido [4,5- c]pyridazine-5,7(6H ,8 H)-diones and 3-aryl-6-ethyl-7-thioxo-7,8-dihydropyrimido [4,5-c ] pyridazin-5(6H) -ones, which were efficiently prepared via a regiospecific one-pot reaction of N -methylbarbituric acid and N -ethyl-2-thiobarbituric acid with various arylglyoxal monohydrates in the presence of hydrazine dihydrochloride in ethanol.
Results and discussion
Recently, glyoxals have attracted much attention in heterocyclic synthetic chemistry. 46 They can be prepared from the corresponding acetophenones via oxidation by SeO 2 in dioxane in reflux conditions. 47 In order to protect the arylglyoxals from oxidation and polymerization, these compounds were converted to their monohydrate isomers. The synthesis of the utilized arylglyoxal monohydrates is shown in Scheme 1.
Scheme 1. Synthesis of arylglyoxal monohydrates.
As shown in Scheme 2, arylglyoxal monohydrates 3a-k were reacted with N -methylbarbituric acid 4a or N -ethyl-2-thiobarbituric acid 4b in the presence of hydrazine dihydrochloride salt in ethanol at 50
• C, leading to the formation of pyrimidopyridazines 5a-v in moderate to good yields. The structures of all twenty-two new examples of these substituted pyrimido [4,5-c ] pyridazines are shown in the Table. Attempts to synthesize the desired pyrimidopyridazines by using hydrazinium hydroxide instead of hydrazine dihydrochloride failed. All new products were characterized as 3-aryl substituted pyrimidopyridazines and there was no evidence of the formation of 4-aryl substituted isomers. This is due to initial regioselective Knoevenageal condensation between hydrated carbonyl of the arylglyoxal monohydrates and barbituric acids (path A). Furthermore, because of regiospecific condensation of the hydrazone intermediate 7 and the carbonyl located in position 4 of the barbituric acids, both CH 3 and CH 3 CH 2 groups were located in position 6 of the pyrimidopyridazine rings (path C). The suggested mechanism for these reactions is shown in Scheme 3. We have previously reported that 3-arylpyrimido [4, 5- 
Experimental

General procedures
All chemicals were purchased from Merck, Aldrich, and Acros. Melting points were determined on an Electrothermal 9200 apparatus. Infrared spectra were recorded on a PerkinElmer Spectrum Two 10.4 spectrometer, using KBr discs. The 1 H NMR and 13 C NMR spectra were recorded on a Bruker AVANCE (300 MHz) spectrometer using d 6 -DMSO as solvent. Microanalyses were performed on a Leco Analyzer 932.
General procedure for the synthesis of 3-aryl-6-methylpyrimido[4,5-c]pyridazine-5,7(6H ,8H )-diones
A mixture of N -methylbarbituric acid (1 mmol) and arylglyoxal monohydrate (1 mmol) in the presence of hydrazine dihydrochloride (1 mmol) in absolute ethanol (10 mL) was heated at 50
• C for 60 min. The obtained precipitate was separated by filtration and washed with excess rectified spirit. The crude products were recrystallized from methanol to give the title compounds in good yields.
3-Phenyl-6-methylpyrimido[4,5-c]pyridazine-5,7(6H ,8H )-dione (5a)
A white powder, 78%, mp 271 
3-(4-Bromophenyl)-6-methylpyrimido[4,5-c]pyridazine-5,7(6H ,8H )-dione (5b)
A gray powder, 82%, mp 275 
3-(4-Fluorophenyl)-6-methylpyrimido[4,5-c]pyridazine-5,7(6H ,8H )-dione (5d)
A white powder, 80%, mp 257 
3-(4-Methoxyphenyl)-6-methylpyrimido[4,5-c]pyridazine-5,7(6H ,8H )-dione (5e)
A yellow powder, 85%, mp 253 
3-(4-Hydroxy-3-methoxyphenyl)-6-methylpyrimido[4,5-c]pyridazine-5,7(6H ,8H )-dione (5j)
An orange powder, 92%, mp 249 
3-(3,4-Methylenedioxyphenyl)-6-methylpyrimido[4,5-c]pyridazine-5,7(6H ,8H )-dione (5k)
A beige powder, 83%, mp 268 
General procedure for the synthesis of 3-aryl-6-ethyl-7-thioxo-7, 8-dihydropyrimido[4,5-c]pyridazine-5(6H )-ones
A mixture of N -ethyl-2-thiobarbituric acid (1 mmol) and arylglyoxal monohydrate (1 mmol) in the presence of hydrazine dihydrochloride (1 mmol) in absolute ethanol (10 mL) was heated at 50
• C for 90 min. The obtained precipitate was separated by filtration and washed with excess rectified spirit. The crude products were purified via recrystallization from methanol.
3-Phenyl-6-ethyl-7-thioxo-7,8-dihydropyrimido[4,5-c]pyridazin-5(6H )-one (5l)
An orange powder, 80%, mp 218 
3-(4-Chlorophenyl)-6-ethyl-7-thioxo-7,8-dihydropyrimido[4,5-c]pyridazin-5(6H )-one (5n)
A brown powder, 79%, mp 232 
3-(4-Fluorophenyl)-6-ethyl-7-thioxo-7,8-dihydropyrimido[4,5-c]pyridazin-5(6H )-one (5o)
A yellow powder, 71%, mp 225 
3-(4-Methoxyphenyl)-6-ethyl-7-thioxo-7,8-dihydropyrimido[4,5-c]pyridazin-5(6H )-one (5p)
A yellow powder, 75%, mp 268 
Conclusions
In summary, we have reported a one-pot reaction for the efficient synthesis of new substituted pyrimido [4,5- c]pyridazine derivatives as potential MAO B inhibitors. By using different types of arylglyoxal monohydrates and barbituric acid derivatives, we obtained novel libraries of pyrimido [4,5-c ] pyridazine derivatives, which make this methodology suitable for combinatorial and parallel synthesis. The proposed reactions proceed in mild conditions and give the products in good yields with high regiospecificity. The separation and purification processes are very simple and convenient, only needing recrystallization. The starting materials are inexpensive and commercially available.
